Adverse events of mepolizumab in the treatment of nasal polyps: A FDA database evaluation. Stephanian B, Liu K, Salazar AM, Saba E, et al. Am J Otolaryngol 2025;46:104517.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Stephanian B, Liu K, Salazar AM, Saba E, et al. Adverse events of mepolizumab in the treatment of nasal polyps: A FDA database evaluation. Am J Otolaryngol 2025;46:104517.
PMID: 39616011